A Phase I/II randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
- The United States Biomedical Advanced Research and Development Authority (BARDA) has announced Vaxxas will receive US$2 million (AU$3.2 million) as a Concept Stage Winner in its multi-stage $50 ...
Waking up with a pimple is no longer a cause for panic, thanks to pimple patches—small, sticker-like bandages that cover and help heal the unwanted zit. A team of researchers publishing in ACS Applied ...
The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
Waking up with a pimple is no longer cause for panic, thanks to pimple patches - small, sticker-like bandages that cover and help heal the unwanted zit. A team of researchers publishing in ACS Applied ...
The Vaxxas high-density microarray patch (HD-MAP) is comprised of thousands of microscopic projections molded into a small patch. Each microprojection is ‘printed’ with a small dose of vaccine in a ...
Waking up with a pimple is no longer cause for panic, thanks to pimple patches — small, sticker-like bandages that cover and help heal the unwanted zit. A team of researchers publishing in ACS Applied ...
- The United States Biomedical Advanced Research and Development Authority (BARDA) has announced Vaxxas will receive US$2 million (AU$3.2 million) as a Concept Stage Winner in its multi-stage $50 ...
This new pimple patch features a specialized array of tiny spikes to help deliver acne-busting compounds under the skin. Waking up with a pimple is no longer cause for panic, thanks to pimple patches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results